EUVIMED · CrossrefJournal
Journal of Managed Care & Specialty Pharmacy
ISSN 2376-0540 · Academy of Managed Care Pharmacy
Latest articles
AMCP Market Insights: Managed care considerations in chronic inflammatory demyelinating polyradiculoneuropathy
AMCP Market Insights: Examining the current and future state of hemophilia B gene therapy in managed care
Discontinuation of glucagon-like peptide-1 receptor agonists among US adults: A national survey
Assessing the impact of pharmacist-led interventions on glucagon-like peptide 1 receptor agonist access and treatment outcomes
State-level variation in the use of glucagon-like peptide-1 receptor agonists for weight loss and diabetes: a real-world analysis
Poster Abstracts - Academy of Managed Care Pharmacy 2026
Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study
Infusion therapy patient outcomes are similar at reduced costs in alternative sites of care compared with hospital outpatient departments: A matched cohort analysis of infusion therapy across multiple chronic conditions
Real-world 6-month persistence, adherence, and effectiveness of GLP-1 medications for overweight and obesity in a Medicaid population
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss–indicated glucagon-like peptide 1 receptor agonists
Beyond glycemic control: Sex differences shaping glucagon-like peptide-1 receptor agonist utilization in the United States
Examining the association between medication adherence trajectories and disease-specific clinical outcomes: An analysis focusing on the drug classes included in Part D quality bonus payments
Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes
Impact of copay maximizers on total patient liability among patients using specialty medicines
Real-world health care costs and resource utilization associated with mild cognitive impairment in the United States: A retrospective cohort study of commercial and Medicare data
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey
Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States
Health care resource utilization and costs of Medicare-enrolled patients with HR+/HER2− metastatic breast cancer treated with a CDK4/6i in the first-line setting
Evaluating estimated health care resource utilization and costs in patients with myelofibrosis based on transfusion status and anemia severity: A retrospective analysis of the Medicare Fee-For-Service claims data
Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period
Patient perceptions of their experience with comprehensive medication reviews: A framework for continued quality improvement
Impact of discontinuing disease-modifying therapies on health care utilization among midlife patients with multiple sclerosis in the United States
Advances in diabetes technology within the digital diabetes ecosystem
A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States
Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review
Patient liability, treatment adherence, and treatment persistence associated with state bans of copay accumulator adjustment programs
Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes
A primer on copay accumulators, copay maximizers, and alternative funding programs
Impact of mental health in persons living with rare disease: Findings from the AMCP Market Insights Program
Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/hyperactivity disorder
EUVIMED